Furthermore, Kalli and co-workers showed that application of anti-IL-10 monotherapy partially inhibited the B16 melanoma and anaplastic large cell lymphoma development, while vaccination with tumor antigen stimulated DCs and anti-IL-10 Abs provided complete protection against melanoma [15]. The gene discussed is IL10; the disease is melanoma.